Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes

Clinical trial NCT00699179 · COMPLETED

Trial details

NCT number: NCT00699179
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Start date: 2008-06-01
Primary completion: 2009-09-01
Enrollment: 2308

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.